Am J Transplant, Volume 22, Suppl 3 Archives - Page 17 of 190 - ATC Abstracts

2022 American Transplant Congress
Fibrin Deposition in Ischemic Damaged Liver Grafts and Reconditioning with Thrombolytic Therapy During Normothermic Machine Perfusion
T. Goto, Y. Noguchi, S. Ganesh, B. Arulratnam, M. Kawamura, C. Parmentier, S. Ray, T. Reichman, N. Selzner, M. Selzner
Ajmera Transplant Program, Department of Surgery, Toronto General Hospital, University Health Network, Toronto, ON, Canada
*Purpose: Normothermic ex situ perfusion (NMP) is a novel technique for the storage and assessment of marginal livers retrieved from donors after circulatory death (DCD).…
2022 American Transplant Congress
ABO Hemagglutination Titres Do Not Accurately Reflect ABO Antibody Levels
A. Halpin¹, T. Ellis², J. Pearcey², B. Motyka², T. L. Lowary³, C. Cairo⁴, S. Maier², L. J. West⁵
¹Pediatrics/Dept of Laboratory Medicine, University of Alberta/Alberta Precision Laboratories, Edmonton, AB, Canada, ²Pediatrics, University of Alberta, Edmonton, AB, Canada, ³Academia Sinica, Institute of Biological Chemistry, Taipei, Taiwan, ⁴Chemistry, University of Alberta, Edmonton, AB, Canada, ⁵Pediatrics, University of Alberta, Canadian Donation and Transplant Research Program, Edmonton, AB, Canada
*Purpose: ABO antibody (ABO-Ab) quantification is essential for risk assessment for ABO-incompatible (ABOi) transplantation, but the hemagglutination assay (HA) for ABO-Ab titres is known to…
2022 American Transplant Congress
PSGL-1-mTOR-TIM3 Signaling in a Murine Model of Hindlimb Transplantation
K. Kadono¹, F. Messner², J. He², Y. Guo², B. Oh², G. Brandacher², J. Kupiec-Weglinski¹
¹UCLA Medical Center, Los Angeles, CA, ²Johns Hopkins UJohns Hopkins University School of Medicine, Baltimore, MD
*Purpose: Peri-transplant tissue damage driven by innate-adaptive immune cascades resulting from ischemia-reperfusion injury (IRI) is a major concern in vascularized composite allotransplantation (VCA). Here, we…
2022 American Transplant Congress
Incidence of Urinary Tract Infection or Asymptomatic Bacteriuria in Kidney Transplant Recipients with Sulfamethoxazole-Trimethoprim vs. Pentamidine for Pneumocystis Jiroveci Pneumonia Prophylaxis
L. Selznick, H. Sweiss, C. Long, S. Bhayana, R. Hall
University Health, San Antonio, TX
*Purpose: To compare the incidence of urinary tract infection (UTI) or asymptomatic bacteriuria (ASB) post-kidney transplant (KT) with multiple Pneumocystis jiroveci pneumonia (PJP) prophylaxis regimens*Methods:…
2022 American Transplant Congress
Nivolumab After Sorafenib Failure in Liver Recipients with HCC Recurrence
J. Kwon
Surgery, Samsung Medical Center, Seoul, Korea, Republic of
*Purpose: Several treatments have recently been known for hepatocellcular carcinoma (HCC) who have failed to treat sorafenib. Immune checkpoint inhibitors have proven to be effective,…
2022 American Transplant Congress
Parathyroid Allo-Transplantation: A Case Series
P. Di Cocco¹, M. Spaggiari², H. Kittle¹, A. M. Fratti², S. Akshelyan², J. Almario Alvarez¹, E. Benedetti², I. Tzvetanov²
¹University of Illinios at Chicago, Chicago, IL, ²University of Illinois at Chicago, Chicago, IL
*Purpose: Hypoparathyroidism (hypoPTH) is a clinical condition characterized by an abnormal mineral homeostasis determined by inadequate secretion of parathyroid hormone. It can be secondary to…
2022 American Transplant Congress
Cryptococcal Meningitis Presenting as SIADH in a Heart Transplant Recipient
D. Blake, M. Ibrahim, E. Hamad, V. Rakita, J. Hoosain, H. Clauss
Temple University Hospital, Philadelphia, PA
*Purpose: Cryptococcal meningitis is a potentially fatal invasive fungal infection in solid organ transplant recipients. Meningoencephalitis is the most common clinical manifestation of cryptococcal infection.…
2022 American Transplant Congress
Robotic Living Donor Nephrectomy: The Future is Now
J. Yu, N. Vaccharajani, S. Matson, M. Scherer, J. Wellen, S. Shenoy, W. Chapman, M. Doyle, A. Khan
Surgery, Washington University School of Medicine, St. Louis, MO
*Purpose: Living donor kidney transplants represent nearly 25% of all kidney transplants performed in the United States. Over the last 10 years, an increasing emphasis…
2022 American Transplant Congress
Association Between Time in Therapeutic Range for Warfarin and Time in Therapeutic Range for Calcineurin Inhibitors in Patients That Received Left Ventricular Assist Devices as Bridge to Transplant
G. Flajc¹, X. Huang², C. Minard², M. Manson¹, Z. Truman¹
¹Baylor St. Luke's Medical Center, Houston, TX, ²Baylor College of Medicine, Houston, TX
*Purpose: Medication nonadherence is a leading cause of avoidable graft failure post-transplant. The relationship between medication adherence in patients with left ventricular assist devices (LVADs)…
2022 American Transplant Congress
Incidence of Opportunistic Infections in Elderly Kidney Transplant Recipients on Belatacept
K. Khalil, S. Jonchhe, J. Stern, R. Robalino, Z. A. Stewart, S. A. Mehta, N. Ali, H. Neumann
Transplant Institute, NYU Langone Health, New York, NY
*Purpose: The purpose of this study was to assess the incidence of opportunistic infections in elderly kidney transplant recipients (KTRs) who receive belatacept (BELA) for…